Cardiovascular manifestations of phaeochromocytoma

Journal of Hypertension

Volumn 29, Issue 11, 2011, Pages 2049-2060

  Prejbisz, Aleksander ^a   Lenders, Jacques W M ^b,c   Eisenhofer, Graeme ^c   Januszewicz, Andrzej ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

arrhythmias; cardiomyopathy; cardiovascular system; complications therapy; emergencies; hypotension; paroxysmal hypertension; phaeochromocytoma

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMISULPRIDE; AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CHLORPROMAZINE; DESIPRAMINE; DOXAZOSIN; DROPERIDOL; FENOLDOPAM; GLYCERYL TRINITRATE; IMIPRAMINE; LABETALOL; METIROSINE; METOCLOPRAMIDE; NADOLOL; NICARDIPINE; NITROPRUSSIDE SODIUM; PHENOXYBENZAMINE; PHENTOLAMINE MESYLATE; PRAZOSIN; PROCHLORPERAZINE; PROPRANOLOL; SOTALOL; SULPIRIDE; TIAPRIDE; TIMOLOL; URAPIDIL; VERALIPRIDE;

ADRENERGIC RECEPTOR BLOCKING; AORTA DISSECTION; CARDIOVASCULAR DISEASE; CATECHOLAMINE RELEASE; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG HALF LIFE; EMERGENCY CARE; HEART ARRHYTHMIA; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPOTENSION; ORTHOSTATIC HYPOTENSION; PERIPHERAL ISCHEMIA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SHOCK; TACHYCARDIA; TAKOTSUBO CARDIOMYOPATHY; TISSUE NECROSIS; UNSPECIFIED SIDE EFFECT;

EID: 80054096098     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834a4ce9     Document Type: Review

References (144)

1. Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 2006; 24:2331-2339. (Pubitemid 44684675)
2. Manger WM, Gifford RW Jr. Clinical and experimental pheochromocytoma. Cambridge, MA: Blackwell Science; 1996.
3. Tolis G, Kuchel O. The multiple faces of the pheochromocytoma. Can Med Assoc J 1977; 116:337-338. (Pubitemid 8057689)
4. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 2005; 90:2110-2116. (Pubitemid 40586247)
5. Brouwers FM, Eisenhofer G, Lenders JW, Pacak K. Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma. Endocrinol Metab Clin North Am 2006; 35:699-724; viii. (Pubitemid 44810888)
6. Brouwers FM, Lenders JW, Eisenhofer G, Pacak K. Pheochromocytoma as an endocrine emergency. Rev Endocr Metab Disord 2003; 4:121-128. (Pubitemid 36547090)
7. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet 2005; 366:665-675. (Pubitemid 41176020)
8. Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 2010; 19:3011-3020.
9. Opocher G, Schiavi F, Cicala MV, Patalano A, Mariniello B, Boaretto F, et al. Genetics of adrenal tumors. Minerva Endocrinol 2009; 34:107-121.
10. Bravo EL. Pheochromocytoma. Cardiol Rev 2002; 10:44-50. (Pubitemid 34130769)
11. Manger WM. The protean manifestations of pheochromocytoma. Horm Metab Res 2009; 41:658-663.
12. Levenson JA, Safar ME, London GM, Simon AC. Haemodynamics in patients with phaeochromocytoma. Clin Sci (Lond) 1980; 58:349-356. (Pubitemid 10060881)
13. Januszewicz W, Wocial B, Sznajderman M, Januszewicz A. Guz chromochlonny. Warszawa: Wydawnictwo Lekarskie PZWL; 2000.
14. Mathias CJ. Role of the central nervous system in human secondary hypertension. J Cardiovasc Pharmacol 1987; 10 (Suppl 12):S93-S99.
15. Plouin PF, Menard J, Corvol P. Noradrenaline producing phaeochromocytomas with absent pressor response to beta-blockade. Br Heart J 1979; 42:359-361. (Pubitemid 10243341)
16. Zelinka T, Strauch B, Petrak O, Holaj R, Vrankova A, Weisserova H, et al. Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients. J Hypertens 2005; 23:2033-2039. (Pubitemid 41830399)
17. Eisenhofer G, Rivers G, Rosas AL, Quezado Z, Manger WM, Pacak K. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management. Drug Saf 2007; 30:1031-1062. (Pubitemid 350036603)
18. Saunders JR, Ferguson AW. Hypertensive crisis in patients with phaeochromocytoma given metoclopramide [letter]. Lancet 1976; 18:1357-1358.
19. Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT, et al. Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 2009; 150:27-32.
20. Bessell-Browne R, O'Malley ME. CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v. administration of nonionic contrast material. AJR Am J Roentgenol 2007; 188:970-974. (Pubitemid 46496928)
21. Mukherjee JJ, Peppercorn PD, Reznek RH, Patel V, Kaltsas G, Besser M, Grossman AB. Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 1997; 202:227-231. (Pubitemid 27024131)
22. Guzik P, Wykretowicz A, Wesseling IK, Wysocki H. Adrenal pheochromocytoma associated with dramatic cyclic hemodynamic fluctuations. Int J Cardiol 2005; 103:351-353. (Pubitemid 41132612)
23. Imai Y, Abe K, Munakata M, Sakuma H, Hashimoto J, Imai K, et al. Does ambulatory blood pressure monitoring improve the diagnosis of secondary hypertension? J Hypertens Suppl 1990; 8:S71-S75.
24. Spieker C, Barenbrock M, Rahn KH, Zidek W. Circadian blood pressure variations in endocrine disorders. Blood Press 1993; 2:35-39. (Pubitemid 23156668)
25. Takabatake T, Yamamoto Y, Ohta H, Nakamura S, Hara H, Ishida Y, et al. Blood pressure variability and hemodynamic response to stress in patients with paroxysmal elevation of blood pressure. Clin Exp Hypertens A 1985; 7:235-242. (Pubitemid 15018459)
26. Zelinka T, Pacak K, Widimsky J Jr. Characteristics of blood pressure in pheochromocytoma. Ann N Y Acad Sci 2006; 1073:86-93. (Pubitemid 44912001)
27. Zelinka T, Strauch B, Pecen L, Widimsky J Jr. Diurnal blood pressure variation in pheochromocytoma, primary aldosteronism and Cushing's syndrome. J Hum Hypertens 2004; 18:107-111. (Pubitemid 38247819)
28. Bravo EL, Tarazi RC, Fouad FM, Textor SC, GiffordRWJr, Vidt DG. Blood pressure regulation in pheochromocytoma. Hypertension 1982; 4:193-199.
29. Bravo E, Fouad-Tarazi F, Rossi G, Imamura M, Lin WW, Madkour MA, et al. A reevaluation of the hemodynamics of pheochromocytoma. Hypertension 1990; 15:I128-I131.
30. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31:68-72. (Pubitemid 28124694)
31. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Muiesan P, et al. Vascular hypertrophy and remodeling in secondary hypertension. Hypertension 1996; 28:785-790. (Pubitemid 26365519)
32. Porteri E, Rizzoni D, Mulvany MJ, De Ciuceis C, Sleiman I, Boari GE, et al. Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans. J Hypertens 2003; 21:2345-2352. (Pubitemid 38293575)
33. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998; 31:335-341.
34. Eisenhofer G, Bornstein SR. Surgery: risks of hemodynamic instability in pheochromocytoma. Nat Rev Endocrinol 2010; 6:301-302.
35. Castellano M, Lenders JW, Plouin PF, Rosei EA. Management of pheochromocytoma-paraganglioma. European Society of Hypertension Scientific Newsletter: update on Hypertension Management 2010; 11:43.
36. Kocak S, Aydintug S, Canakci N. Alpha blockade in preoperative preparation of patients with pheochromocytomas. Int Surg 2002; 87:191-194.
37. Prys-Roberts C, Farndon JR. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 2002; 26:1037-1042. (Pubitemid 36920305)
38. Bruynzeel H, Feelders RA, Groenland TH, van den Meiracker AH, van Eijck CH, Lange JF, et al. Risk factors for hemodynamic instability during surgery for pheochromocytoma. J Clin Endocrinol Metab 2010; 95:678-685.
39. Zhu Y, He HC, Su TW, Wu YX, Wang WQ, Zhao JP, et al. Selective alpha1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma. Endocrine 2010; 38:254-259.
40. Weingarten TN, Cata JP, O'Hara JF, Prybilla DJ, Pike TL, Thompson GB, et al. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 2010; 76:508.e6-508.e11.
41. Attar MN, Moulik PK, Salem GD, Rose EL, Khaleeli AA. Phaeochromocytoma presenting as dilated cardiomyopathy. Int J Clin Pract 2003; 57:547-548. (Pubitemid 36974899)
42. Rosas AL, Kasperlik-Zaluska AA, Papierska L, Bass BL, Pacak K, Eisenhofer G. Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur J Endocrinol 2008; 158:423-429. (Pubitemid 351405009)
43. Alijotas-Reig J, Bove-Farre I, de Cabo-Frances F, Angles-Coll R. Effectiveness and safety of prehospital urapidil for hypertensive emergencies. Am J Emerg Med 2001; 19:130-133. (Pubitemid 32205273)
44. Munakata M, Aihara A, Imai Y, Noshiro T, Ito S, Yoshinaga K. Altered sympathetic and vagal modulations of the cardiovascular system in patients with pheochromocytoma: their relations to orthostatic hypotension. Am J Hypertens 1999; 12:572-580. (Pubitemid 29268388)
45. Streeten DH, Anderson GH Jr. Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma. Am J Hypertens 1996; 9:760-769.
46. Moriguchi A, Otsuka A, Kohara K, Mikami H, Ogihara T. Evaluation of orthostatic hypotension using power spectral analysis. Am J Hypertens 1993; 6:198-203. (Pubitemid 23109447)
47. Baxter MA, Hunter P, Thompson GR, London DR. Phaeochromocytomas as a cause of hypotension. Clin Endocrinol (Oxf) 1992; 37:304-306.
48. Takagi S, Miyazaki S, Fujii T, Daikoku S, Sutani Y, Morii I, et al. Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Jpn Circ J 2000; 64:785-788.
49. Brukamp K, Goral S, Townsend RR, Silvestry FE, Torigian DA. Rapidly reversible cardiogenic shock as a pheochromocytoma presentation. Am J Med 2007; 120:e1-e2. (Pubitemid 47313331)
50. Grasselli G, Foti G, Patroniti N, Rona R, Perlangeli MV, Pesenti A. Extracorporeal cardiopulmonary support for cardiogenic shock caused by pheochromocytoma: a case report and literature review. Anesthesiology 2008; 108:959-962. (Pubitemid 351589493)
51. Kizer JR, Koniaris LS, Edelman JD, St John Sutton MG. Pheochromocytoma crisis, cardiomyopathy, and hemodynamic collapse. Chest 2000; 118:1221-1223.
52. Roberts-Thomson KC, Psaltis PJ, DeAngelis E. Cardiogenic shock in a young woman. Cardiology 2006; 105:182-183.
53. Wu GY, Doshi AA, Haas GJ. Pheochromocytoma induced cardiogenic shock with rapid recovery of ventricular function. Eur J Heart Fail 2007; 9:212-214. (Pubitemid 46394072)
54. De Wilde D, Velkeniers B, Huyghens L, Diltoer M. The paradox of hypotension and pheochromocytoma: a case report. Eur J Emerg Med 2004; 11:237-239.
55. Schifferdecker B, Kodali D, Hausner E, Aragam J. Adrenergic shock: an overlooked clinical entity? Cardiol Rev 2005; 13:69-72. (Pubitemid 40279873)
56. Murai K, Hirota K, Niskikimi T, Kawarabayashi T, Yoshiyama M, Yasuda M, et al. Pheochromocytoma with electrocardiographic change mimicking angina pectoris, and cyclic change in direct arterial pressure: a case report. Angiology 1991; 42:157-161.
57. Mirza A. Myocardial infarction resulting from nonatherosclerotic coronary artery diseases. Am J Emerg Med 2003; 21:578-584. (Pubitemid 37494051)
58. Darze ES, Von Sohsten RL. Pheochromocytoma-induced segmental myocardial dysfunction mimicking an acute myocardial infarction in a patient with normal coronary arteries. Arq Bras Cardiol 2004; 82:178-180; 175-177.
59. Brown H, Goldberg PA, Selter JG, Cabin HS, Marieb NJ, Udelsman R, Setaro JF. Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J Clin Endocrinol Metab 2005; 90:563-569. (Pubitemid 40116709)
60. Babinska A, Gnacinska A, Swiatkowska-Stodulska R, Sworczak K. Myocardial infarction in a 30-year-old patient with pheochromocytoma and type 1 neurofibromatosis. Pol Arch Med Wewn 2008; 118:517-523.
61. Garg A, Banitt PF. Pheochromocytoma and myocardial infarction. South Med J 2004; 97:981-984. (Pubitemid 39391828)
62. Zangrillo A, Valentini G, Casati A, Torri G. Myocardial infarction and death after caesarean section in a woman with protein S deficiency and undiagnosed phaeochromocytoma. Eur J Anaesthesiol 1999; 16:268-270. (Pubitemid 29195414)
63. Adameova A, Abdellatif Y, Dhalla NS. Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease. Can J Physiol Pharmacol 2009; 87:493-514.
64. Fouad-Tarazi FM, Imamura M, Bravo EL, Rossi G, Nagi HK, Lin WW, et al. Differences in left ventricular structural and functional changes between pheochromocytoma and essential hypertension. Role of elevated circulating catecholamines. Am J Hypertens 1992; 5:134-140.
65. Shub C, Cueto-Garcia L, Sheps SG, Ilstrup DM, Tajik AJ. Echocardiographic findings in pheochromocytoma. Am J Cardiol 1986; 57:971-975. (Pubitemid 16055645)
66. Denolle T, Chatellier G, Julien J, Battaglia C, Luo P, Plouin PF. Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. Am J Hypertens 1993; 6:907-913. (Pubitemid 23363177)
67. Baratella MC, Menti L, Angelini A, Daliento L. An unusual case of myocarditis. Int J Cardiol 1998; 65:305-310. (Pubitemid 28368339)
68. Chedid A, Amar L, Bobrie G, Plouin PF. Prevalence and presentation of acute adrenergic cardiomyopathy in patients with pheochromocytoma or paraganglioma. J Hypertens 2009; 27 (suppl 4):S36.
69. Curylo A, Jankowski P, Kawecka-Jaszcz K. Pheochromocytoma mimicking acute myocarditis. Kardiol Pol 2004; 60:145-148. (Pubitemid 38279774)
70. Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associated with pheochromocytoma. N Engl J Med 1966; 274:1102-1108.
71. Armstrong BK, Beahan PG, Leedman RL. Phaeochromocytoma with catecholamine cardiomyopathy successfully treated surgically. Aust N Z J Med 1972; 2:402-404.
72. Baker G, Zeller NH, Weitzner S, Leach JK. Pheochromocytoma without hypertension presenting as cardiomyopathy. Am Heart J 1972; 83:688-693.
73. Brilakis ES, Young WF Jr, Wilson JW, Thompson GB, Munger TM. Reversible catecholamine-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. J Heart Lung Transplant 1999; 18:376-380. (Pubitemid 29205275)
74. Elian D, Harpaz D, Sucher E, Kaplinsky E, Motro M, Vered Z. Reversible catecholamine-induced cardiomyopathy presenting as acute pulmonary edema in a patient with pheochromocytoma. Cardiology 1993; 83:118-120. (Pubitemid 23301346)
75. Gordon RY, Fallon JT, Baran DA. Case report: a 32-year-old woman with familial parangangliomas and acute cardiomyopathy. Transplant Proc 2004; 36:2819-2822. (Pubitemid 40036846)
76. Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED Jr. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 1987; 316:793-797. (Pubitemid 17046089)
77. Kim J, Reutrakul S, Davis DB, Kaplan EL, Refetoff S. Multiple endocrine neoplasia 2A syndrome presenting as peripartum cardiomyopathy due to catecholamine excess. Eur J Endocrinol 2004; 151:771-777. (Pubitemid 40090018)
78. Mishra AK, Agarwal G, Kapoor A, Agarwal A, Bhatia E, Mishra SK. Catecholamine cardiomyopathy in bilateral malignant pheochromocytoma: successful reversal after surgery. Int J Cardiol 2000; 76:89-90.
79. Mootha VK, Feldman J, Mannting F, Winters GL, Johnson W. Pheochromocytoma-induced cardiomyopathy. Circulation 2000; 102:E11-E13.
80. Sadowski D, Cujec B, McMeekin JD, Wilson TW. Reversibility of catecholamine-induced cardiomyopathy in a woman with pheochromocytoma. CMAJ 1989; 141:923-924.
81. Sardesai SH, Mourant AJ, Sivathandon Y, Farrow R, Gibbons DO. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J 1990; 63:234-237. (Pubitemid 20129054)
82. Velasquez G, D'Souza VJ, Hackshaw BT, Glass TA, Formanek AG. Phaeochromocytoma and cardiomyopathy. Br J Radiol 1984; 57:89-92. (Pubitemid 14081086)
83. Dalby MC, Burke M, Radley-Smith R, Banner NR. Pheochromocytoma presenting after cardiac transplantation for dilated cardiomyopathy. J Heart Lung Transplant 2001; 20:773-775. (Pubitemid 32633880)
84. Gianni M, Dentali F, Grandi AM, Sumner G, Hiralal R, Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006; 27:1523-1529. (Pubitemid 43954909)
85. Jindal V, Baker ML, Aryangat A, Wittlin SD, Bisognano JD, Richter HS. Pheochromocytoma: presenting with regular cyclic blood pressure and inverted Takotsubo cardiomyopathy. J Clin Hypertens (Greenwich) 2009; 11:81-86.
86. Lassnig E, Weber T, Auer J, Nomeyer R, Eber B. Pheochromocytoma crisis presenting with shock and tako-tsubo-like cardiomyopathy. Int J Cardiol 2009; 134:e138-e140.
87. Pfister R, Diedrichs H, Dietlein M, Erdmann E, Schneider CA. Typical and atypical takotsubo-like cardiomyopathy as a manifestation of pheochromocytoma. J Endocrinol Invest 2008; 31:382-383. (Pubitemid 351796628)
88. Zegdi R, Parisot C, Sleilaty G, Deloche A, Fabiani JN. Pheochromocytoma-induced inverted Takotsubo cardiomyopathy: a case of patient resuscitation with extracorporeal life support. J Thorac Cardiovasc Surg 2008; 135:434-435. (Pubitemid 351181316)
89. De Backer TL, De Buyzere ML, Taeymans Y, Kunnen P, Rubens R, Clement DL. Cardiac involvement in pheochromocytoma. J Hum Hypertens 2000; 14:469-471. (Pubitemid 30461935)
90. Zielen P, Klisiewicz A, Januszewicz A, Prejbisz A, Kabat M, Peczkowska M, et al. Pheochromocytoma-related 'classic' takotsubo cardiomyopathy. J Hum Hypertens 2010; 24:363-366.
91. Galiuto L, De Caterina AR, Porfidia A, Paraggio L, Barchetta S, Locorotondo G, et al. Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in apical ballooning or Tako-Tsubo syndrome. Eur Heart J 2010; 31:1319-1327.
92. Haghi D, Papavassiliu T, Fluchter S, Kaden JJ, Porner T, Borggrefe M, Suselbeck T. Variant form of the acute apical ballooning syndrome (takotsubo cardiomyopathy): observations on a novel entity. Heart 2006; 92:392-394.
93. Sanchez-Recalde A, Costero O, Oliver JM, Iborra C, Ruiz E, Sobrino JA. Images in cardiovascular medicine. Pheochromocytoma-related cardiomyopathy: inverted Takotsubo contractile pattern. Circulation 2006; 113:e738-e739.
94. Takizawa M, Kobayakawa N, Uozumi H, Yonemura S, Kodama T, Fukusima K, et al. A case of transient left ventricular ballooning with pheochromocytoma, supporting pathogenetic role of catecholamines in stress-induced cardiomyopathy or takotsubo cardiomyopathy. Int J Cardiol 2007; 114:e15-e17. (Pubitemid 44791483)
95. Cohen CD, Dent DM. Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgrad Med J 1984; 60:111-115. (Pubitemid 14182880)
96. de Leeuw PW, Waltman FL, Birkenhager WH. Noncardiogenic pulmonary edema as the sole manifestation of pheochromocytoma. Hypertension 1986; 8:810-812. (Pubitemid 16049587)
97. Naeije R, Yernault JC, Goldstein M, Corhil A. Acute pulmonary oedema in a patient with phaeochromocytoma. Intensive Care Med 1978; 4:165-167. (Pubitemid 8395727)
98. Sukoh N, Hizawa N, Yamamoto H, Suzuki A. Increased neutrophils in bronchoalveolar lavage fluids from a patient with pulmonary edema associated with pheochromocytoma. Intern Med 2004; 43:1194-1197. (Pubitemid 40074160)
99. Takeshita T, Shima H, Oishi S, Machida N, Uchiyama K. Noncardiogenic pulmonary edema as the first manifestation of pheochromocytoma: a case report. Radiat Med 2005; 23:133-138.
100. Dabrowska B, Dabrowski A, Pruszczyk P, Skrobowski A, Wocial B. Heart rate variability before sudden blood pressure elevations or complex cardiac arrhythmias in phaeochromocytoma. J Hum Hypertens 1996; 10:43-50. (Pubitemid 26057295)
101. Dabrowska B, Feltynowski T, Wocial B, Szpak W, Januszewicz W. Effect of removal of phaeochromocytoma on diurnal variability of blood pressure, heart rhythm and excretion of catecholamines. J Hum Hypertens 1990; 4:397-399. (Pubitemid 20260457)
102. Dabrowska B, Pruszczyk P, Dabrowski A, Feltynowski T, Wocial B, Januszewicz W. Influence of alpha-adrenergic blockade on ventricular arrhythmias, QTc interval and heart rate variability in phaeochromocytoma. J Hum Hypertens 1995; 9:925-929.
103. Donckier JE, Delgrange E, Michel L. ECG abnormalities of endocrine origin. Heart 2001; 85:679.
104. Forde TP, Yormak SS, Killip T 3rd. Reflex bradycardia and nodal escape rhythm in pheochromocytoma. Am Heart J 1968; 76:388-392.
105. Sesay M, Tauzin-Fin P, Gosse P, Ballanger P, Maurette P. Real-time heart rate variability and its correlation with plasma catecholamines during laparoscopic adrenal pheochromocytoma surgery. Anesth Analg 2008; 106:164-170; table of contents.
106. Lydakis C, Hollinrake K, Lip GY. An unusual cause of palpitations requiring atrioventricular node ablation and pacemaker therapy. Blood Press 1997; 6:368-371. (Pubitemid 28078827)
107. Gurlek A, Erol C. Pheochromocytoma with asymmetric septal hypertrophy and Wolff-Parkinson-White syndrome. Int J Cardiol 1991; 32:403-405.
108. McNeill AJ, Adgey AA, Wilson C. Recurrent ventricular arrhythmias complicating myocardial infarction in the presence of phaeochromocytoma. Br Heart J 1992; 67:97-98.
109. Methe H, Hinterseer M, Wilbert-Lampen U, Beckmann BM, Steinbeck G, Kaab S. Torsades de Pointes: a rare complication of an extra-adrenal pheochromocytoma. Hypertens Res 2007; 30:1263-1266. (Pubitemid 351176425)
110. Michaels RD, Hays JH, O'Brian JT, Shakir KM. Pheochromocytoma associated ventricular tachycardia blocked with atenolol. J Endocrinol Invest 1990; 13:943-947.
111. Paschalis-Purtak K, Pucilowska B, Prejbisz A, Januszewicz A. Cardiac arrests, atrioventricular block, and pheochromocytoma. Am J Hypertens 2004; 17:544-545. (Pubitemid 38726172)
112. Stenstrom G, Swedberg K. QRS amplitudes, QTc intervals and ECG abnormalities in pheochromocytoma patients before, during and after treatment. Acta Med Scand 1988; 224:231-235.
113. Shimizu K, Miura Y, Meguro Y, Noshiro T, Ohzeki T, Kusakari T, et al. QT prolongation with torsade de pointes in pheochromocytoma. Am Heart J 1992; 124:235-239.
114. Nicholas E, Deutschman CS, Allo M, Rock P. Use of esmolol in the intraoperative management of pheochromocytoma. Anesth Analg 1988; 67:1114-1117. (Pubitemid 18260761)
115. Beatty OL, Russell CF, Kennedy L, Hadden DR, Kennedy TL, Atkinson AB. Phaeochromocytoma in northern Ireland: a 21 year review. Eur J Surg 1996; 162:695-702.
116. Fox JM, Manninen PH. The anaesthetic management of a patient with a phaeochromocytoma and acute stroke. Can J Anaesth 1991; 38:775-779.
117. Goswami R, Tandon N, Singh B, Kochupillai N. Adrenal tumour, congestive heart failure and hemiparesis in an 18-year-old male. A clinicalpathological conference. Int J Cardiol 1995; 49:233-238.
118. Hill JB, Schwartzman RJ. Cerebral infarction and disseminated intravascular coagulation with pheochromocytoma. Arch Neurol 1981; 38:395. (Pubitemid 11070221)
119. Moritani H, Sakamoto M, Yoshida Y, Nasu H, Nemoto R, Nakamura I. Pheochromocytoma of the urinary bladder revealed with cerebral hemorrhage. Intern Med 2001; 40:638-642. (Pubitemid 32799388)
120. Plouin PF, Duclos JM, Soppelsa F, Boublil G, Chatellier G. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center. J Clin Endocrinol Metab 2001; 86:1480-1486. (Pubitemid 32374890)
121. Azizi M, Fumeron C, Jebara V, Day M, Fagon JY, Plouin PF. Phaeochromocytoma revealed by type A acute aortic dissection. J Hum Hypertens 1994; 8:69-70. (Pubitemid 24052191)
122. Ehata T, Karasawa F, Watanabe K, Satoh T. Unsuspected pheochromocytoma with abdominal aortic aneurysm: a case report. Acta Anaesthesiol Sin 1999; 37:27-28.
123. Krane NK. Clinically unsuspected pheochromocytomas. Experience at Henry Ford Hospital and a review of the literature. Arch Intern Med 1986; 146:54-57. (Pubitemid 16158627)
124. Triplett JC, Atuk NO. Dissecting aortic aneurysm associated with pheochromocytoma. South Med J 1975; 68:748-753.
125. Buchholz S, Lutchmann D, Keightley C. Cardiovascular flashlight. Phaeochromocytoma: delayed diagnosis with severe consequences. Eur Heart J 2010; 31:1336.
126. Januszewicz W, Wocial B. Clinical and biochemical aspects of pheochromocytoma. Report of 110 cases. Cardiology 1985;72(Suppl 1):131-136. (Pubitemid 16146029)
127. Scharf Y, Nahir M, Plavnic Y, Ben-Arieh J, Lichtig C, Gellei B. Intermittent claudiation with pheochromocytoma. JAMA 1971; 215:1323-1324.
128. Tack CJ, Lenders JW. Pheochromocytoma as a cause of blue toes. Arch Intern Med 1993; 153:2061.
129. May EE, Beal AL, Beilman GJ. Traumatic hemorrhage of occult pheochromocytoma: a case report and review of the literature. Am Surg 2000; 66:720-724. (Pubitemid 30626856)
130. Mohamed HA, Aldakar MO, Habib N. Cardiogenic shock due to acute hemorrhagic necrosis of a pheochromocytoma: a case report and review of the literature. Can J Cardiol 2003; 19:573-576. (Pubitemid 36705625)
131. Moran ME, Rosenberg DJ, Zornow DH. Pheochromocytoma multisystem crisis. Urology 2006; 67:846.e19-846.e20.
132. Newell KA, Prinz RA, Pickleman J, Braithwaite S, Brooks M, Karson TH, Glisson S. Pheochromocytoma multisystem crisis. A surgical emergency. Arch Surg 1988; 123:956-959.
133. Caputo C, Fishbane S, Shapiro L, Courgi RG, Kostadinov S, Donovan V, Epstein D. Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritis. Am J Kidney Dis 2002; 39:E23.
134. Herbland A, Bui N, Rullier A, Vargas F, Gruson D, Hilbert G. Multiple organ failure as initial presentation of pheochromytoma. Am J Emerg Med 2005; 23:565-566. (Pubitemid 41008016)
135. Kolhe N, Stoves J, Richardson D, Davison AM, Gilbey S. Hypertension due to phaeochromocytoma: an unusual cause of multiorgan failure. Nephrol Dial Transplant 2001; 16:2100-2104. (Pubitemid 32970581)
136. Kang JM, Lee WJ, Kim WB, Kim TY, Koh JM, Hong SJ, et al. Systemic inflammatory syndrome and hepatic inflammatory cell infiltration caused by an interleukin-6 producing pheochromocytoma. Endocr J 2005; 52:193-198. (Pubitemid 40745706)
137. Mok CC, Ip TP, So CC. Phaeochromocytoma with adult respiratory distress syndrome mimicking septicaemic shock. Med J Aust 1997; 166:634-635.
138. Brunt LM. Phaeochromocytoma in pregnancy. Br J Surg 2001; 88:481-483. (Pubitemid 32291226)
139. Feltynowski T, Januszewicz W, Jakubowski W, Pacho R, Wocial R, Szostek M, Staszkiewicz W. Intrapericardial pheochromocytoma: a case report. Cor Vasa 1990; 32:145-148. (Pubitemid 20172930)
140. Jebara VA, Uva MS, Farge A, Acar C, Azizi M, Plouin PF, et al. Cardiac pheochromocytomas. Ann Thorac Surg 1992; 53:356-361.
141. Pickering TG, Isom OW, Bergman GW, Barbieri JM. Pheochromocytoma of the heart. Am J Cardiol 2000; 86:1288-1289; A1210.
142. Saad MF, Frazier OH, Hickey RC, Samaan NA. Intrapericardial pheochromocytoma. Am J Med 1983; 75:371-376. (Pubitemid 13030883)
143. Shimoyama Y, Kawada K, Imamura H. A functioning intrapericardial paraganglioma (pheochromocytoma). Br Heart J 1987; 57:380-383. (Pubitemid 17055810)
144. Stowers SA, Gilmore P, Stirling M, Morantz JM, Miller AB, Meyer LJ, et al. Cardiac pheochromocytoma involving the left main coronary artery presenting with exertional angina. Am Heart J 1987; 114:423-427. (Pubitemid 17131738)